|
FY2020
12 months to Mar 31, 2020
|
FY2019
12 months to Mar 31, 2019
|
FY2018
12 months to Mar 31, 2018
|
FY2017
12 months to Mar 31, 2017
|
FY2016
12 months to Mar 31, 2016
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Operating costs and expenses: | |||||
| Cost of sales | |||||
| Selling, general and administrative expenses | |||||
| Research and development | |||||
| Restructuring charges | |||||
| Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down | |||||
| Net (gain) loss on sales and disposals of assets | |||||
| Total operating costs and expenses | |||||
| Operating income | |||||
| Non-operating (income) expense: | |||||
| Interest income | |||||
| Interest expense | |||||
| Business combination bargain purchase, gain recognized | |||||
| Change in value of TOKIN options | |||||
| Gain (Loss) Related to Litigation Settlement | |||||
| Other (income) expense, net | |||||
| Income before income taxes and equity income (loss) from equity method investments | |||||
| Income tax expense (benefit) | |||||
| Income before equity income (loss) from equity method investments | |||||
| Equity income (loss) from equity method investments | |||||
| Net income | |||||
| Net income (loss) per basic share: | |||||
| Net income (loss) (in dollars per share) | |||||
| Net income (loss) per diluted share: | |||||
| Net income (loss) (in dollars per share) | |||||
| Common Stock, Dividends, Per Share, Declared | |||||
| Weighted-average shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...